Gordonia sputi Details: NCBI 36823, high G+C gram-positive [species]

| ATCC 29627| ATCC 33609 [[Rhodococcus chubuensis Tsukamura 1983]]| ATCC 33610 [[Rhodococcus obuensis Tsukamura 1983]]| CCUG 47138| CIP 100849| DSM 43896| DSM 44019 [[Rhodococcus chubuensis Tsukamura 1983]]| Gordona sputi| Gordonia sputi| Gordonia sputi (Tsukamura 1978) Stackebrandt et al. 1989 emend. Riegel et al. 1994| Gordonia sputi (Tsukamura 1978) Stackebrandt et al. 1989 emend. Tsukamura 1991| IFO 16049| JCM 3228| JCM 6047 [[Rhodococcus chubuensis Tsukamura 1983]]| NBRC 100414| NBRC 16049| Rhodococcus chubuensis| Rhodococcus chubuensis Tsukamura 1983| Rhodococcus obuensis| Rhodococcus obuensis Tsukamura 1983| Rhodococcus sputi| Rhodococcus sputi (ex Tsukamura 1978) Tsukamura and Yano 1985| Rhodococcus sputi Tsukamura 1978 (Approved Lists 1980)| strain E6324 [[Rhodococcus chubuensis Tsukamura 1983]]| strain E8179 [[Rhodococcus obuensis Tsukamura 1983]]

  1. Rare Infections: Gordonia sputi and other Gordonia species have been implicated in rare cases of human infections. These infections are typically opportunistic and may occur in immunocompromised individuals or those with underlying medical conditions. Infections caused by Gordonia sputi may manifest as localized infections, abscesses, or systemic infections.

  2. Clinical Presentation: The clinical presentation of infections caused by Gordonia sputi may vary depending on the site of infection and the host's immune status. Common presentations include skin and soft tissue infections, pulmonary infections, bloodstream infections, or infections of indwelling medical devices.

  3. Antibiotic Susceptibility: Gordonia species, including Gordonia sputi, are often resistant to multiple antibiotics, including beta-lactams, macrolides, and fluoroquinolones. Treatment of infections caused by Gordonia sputi may require multidrug regimens and prolonged courses of antibiotics, guided by antimicrobial susceptibility testing.

  4. Laboratory Identification: Gordonia species may be misidentified or overlooked in clinical microbiology laboratories due to their similarity to other bacteria, particularly mycobacteria. Accurate identification of Gordonia sputi is important for appropriate diagnosis and management of infections.

Visuals of Interactions with other bacteria of the same rank

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Gordonia sputi

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.04 37 37 37 37 37 37 0 %ile 100 %ile
ubiome 0.13 0 37 37 37 37 37 0 %ile 99 %ile

External Reference Ranges for Gordonia sputi

Gordonia sputi (NCBI 36823) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Gordonia sputi
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
uBiome 0.125 %   0.004 %  % 1.0 802

To see medical conditions associated you may be logged in

And display level must be raised above public.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]